David Hallal is the founder of ElevateBio. ElevateBio has raised $1.3B in total funding. Latest round: Series D. Based in Cambridge, United States.
David Hallal is the CEO of ElevateBio, a technology-driven company focused on powering the creation of life-transforming cell and gene therapies. The Waltham, Massachusetts-based biotech has raised approximately $1.25 billion in the last five and a half years. ElevateBio has inked partnerships with companies like Novo Nordisk, with one potentially valuing around $2 billion in biobucks. The company is focused on building out its technology platforms and manufacturing business.
Full founder directory · Investor directory · Company funding database · Fundraising library